Papillomavirus Infections

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-07-09
EMA Authorised: Cervarix (human papillomavirus1 type 16 L1 protein;human papillomavirus type 18 L1 protein) — GlaxoSmithKline Biologicals S.A.
Cervarix, a vaccine targeting HPV types 16 and 18, has been authorised by the EMA for use in immunization against papillomavirus infections …